Post vaccine considerations for personnel

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  Updated Dec. 13, 2020
  
  Infection prevention and control considerations for healthcare personnel with systemic signs and symptoms following COVID-19 vaccination
  
  Note: Strategies are needed for healthcare facilities to appropriately evaluate and manage post-vaccination signs and symptoms among healthcare personnel (HCP). The approach described in this document is intended to reduce the risks for disruptions in care and pathogen (e.g., SARS-CoV-2) transmission resulting from:
  
  • unnecessarily excluding HCP with only post-vaccination signs and symptoms from work, and
  
  • inadvertently allowing HCP with SARS-CoV-2 or another transmissible infection to work.
  
  These considerations are based on the current understanding of signs and symptoms following COVID-19 vaccination, including timing and duration, and might change as experience with the vaccine accumulates.
  
  
• Subjects:
  Coronavirus Infections/prevention & Control COVID-19 Vaccines Drug-Related Side Effects And Adverse Reactions Health Personnel Vaccination Viral Vaccines
• Document Type:
  Webpage
• Place as Subject:
  United States
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:8b0cf01a5e7664adcf5f3034a8831310767e671e98e126ace0f0be57b6cf9923
• Download URL:
  https://stacks.cdc.gov/view/cdc/98784/cdc_98784_DS1.pdf
• File Type:
  [PDF - 124.45 KB ]